Advertisement

Colon and Rectum Carcinoma Surveillance Counterpoint: USA

  • Mohamedtaki A. TejaniEmail author
  • Steven J. Cohen
Chapter
Part of the Current Clinical Oncology book series (CCO)

Abstract

Colorectal adenocarcinoma is a leading cause of cancer-related death in the United States, accounting for more than estimated 50,000 deaths in each year [1]. Approximately two thirds of patients present with potentially curable disease. This group of patients undergoes surgical resection with or without adjuvant treatment (chemotherapy with or without radiation).

Keywords

Colonoscopy Detection strategies US 

References

  1. 1.
    Jemal A, Siegel R, Xu J, Ward E. Cancer statistics. CA Cancer J Clin. 2010;60:277–300.PubMedCrossRefGoogle Scholar
  2. 2.
    Guyot F, Faivre J, Manfredi S, et al. Time trends in the treatment and survival of recurrences from colorectal cancer. Ann Oncol. 2005;16:756–61.PubMedCrossRefGoogle Scholar
  3. 3.
    Tomlinson JS, Jarnagin WR, DeMatteo RP, et al. Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol. 2007;25:4575–80.PubMedCrossRefGoogle Scholar
  4. 4.
    Schoemaker D, Black R, Giles L, Toouli J. Yearly colonoscopy, liver CT and chest radiography do not influence 5-year survical of colorectal cancer patients. Gastroenterology. 1998;114:7–14.PubMedCrossRefGoogle Scholar
  5. 5.
    Pietra N, Sarli L, Costi R, Ouchemi C, Grattarola M, Peracchia A. Role of follow-up in management of local recurrences of colorectal cancer: a prospective, randomized trial. Dis Colon Rectum. 1998;41:1127–33.PubMedCrossRefGoogle Scholar
  6. 6.
    Kjeldsen BJ, Kronborg O, Fenger C, Jorgensen OD. A prospective randomized study of follow-up after radical surgery for colorectal cancer. Br J Surg. 1997;84:666–9.PubMedCrossRefGoogle Scholar
  7. 7.
    Ohlsson B, Breland U, Ekberg H, et al. Follow-up after curative surgery for colorectal carcinoma: randomized comparison with no follow-up. Dis Colon Rectum. 1995;38:619–26.PubMedCrossRefGoogle Scholar
  8. 8.
    Makela JT, Laitinen SO, Kairaluoma MI. Five-year follow-up after radical surgery for colorectal cancer: results of a prospective randomized trial. Arch Surg. 1995;130:1062–7.PubMedCrossRefGoogle Scholar
  9. 9.
    Secco GB, Fardelli R, Gianquinto D, et al. Efficacy and cost of risk-adapted follow-up in patients after colorectal cancer surgery: a prospective, randomized and controlled trial. Eur J Surg Oncol. 2002;28:418–23.PubMedCrossRefGoogle Scholar
  10. 10.
    Ovaska J, Jarvinen H, Kujari H, Pertilla I, Mecklin JP. Follow-up of patients operated on for colorectal carcinoma. Am J Surg. 1990;159:593–6.PubMedCrossRefGoogle Scholar
  11. 11.
    Rodriguez-Moranta F, Salo J, Arcusa A, et al. Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial. J Clin Oncol. 2006;24:386–93.PubMedCrossRefGoogle Scholar
  12. 12.
    Figueredo A, Rumble RB, Maroun J, et al. Follow-up of patients with curatively resected colorectal cancer: a practice guideline. BMC Cancer. 2003;3:26.PubMedCrossRefGoogle Scholar
  13. 13.
    Renehan AG, Egger M, Saunders MP, et al. Impact on survival of intense follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomized trials. BMJ. 2002;324:813.PubMedCrossRefGoogle Scholar
  14. 14.
    Jeffery GM, Hickey BE, Hider P. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev. 2002;1:CD002200.Google Scholar
  15. 15.
    NCCN colon cancer clinical practice guidelines in oncology. J Natl Compr Cancer Network. 2008;1:1–18.Google Scholar
  16. 16.
    Kjeldsen BJ, Kronborg O, Fenger C, Jorgensen OD. The pattern of recurrent colorectal cancer in a prospective randomized study and the characteristics of diagnostic tests. Int J Colorectal Dis. 1997;12:329–34.PubMedCrossRefGoogle Scholar
  17. 17.
    Sargent D, Sobrero A, Grothey A, et al. Evidence for cure by adjuvant therapy in Colon Cancer: observations based on individual patient data from 20, 898 patients on 18 randomized trials. J Clin Oncol. 2009;6:872–7.CrossRefGoogle Scholar
  18. 18.
    Gold P, Freedman SO. Demonstration of tumor-specific antigens in colonic carcinomata by immunological tolerance and absorption techniques. J Exp Med. 1965;121:439–62.PubMedCrossRefGoogle Scholar
  19. 19.
    Arnaud JP, Koehl C, Adloff M. Carcinoembryonic antigen (CEA) in the diagnosis and prognosis of colorectal carcinoma. Dis Colon Rectum. 1980;23:141–4.PubMedCrossRefGoogle Scholar
  20. 20.
    Libutti SK, Alexander HR, Choyke P, et al. A prospective study of 2-[18F] fluoro-2-deoxy-D-glucose/positron emission tomography scan, 99 m Tc-labeled arcitumomab (CEA-scan), and blind second-look laparotomy for detecting colon cancer recurrence in patients with increasing CEA levels. Ann Surg Oncol. 2001;8:779–86.PubMedCrossRefGoogle Scholar
  21. 21.
    Tsikitis VL, Malireddy K, Green EA, et al. Postoperative recommendations for early stage colon cancer based on results from the clinical outcomes of surgical therapy trial. J Clin Oncol. 2009;22:3671–6.CrossRefGoogle Scholar
  22. 22.
    Green RJ, Metlay JP, Propert K, et al. Surveillance for second primary colorectal cancer after adjuvant chemotherapy: an analysis of Intergroup 0089. Ann Intern Med. 2002;136:261–9.PubMedGoogle Scholar
  23. 23.
    Graffner H, Hultberg B, Johansson B, Moller T, Petersson BG. Detection of recurrent cancer of the colon and rectum. J Surg Oncol. 1985;28:156–9.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press 2013

Authors and Affiliations

  1. 1.Fox Chase Cancer CenterPhiladelphiaUSA

Personalised recommendations